| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/19/2013 | US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130244988 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/18/2013 | EP2638012A1 Pyridyl ureas as mineralocorticoid receptor antagonists |
| 09/18/2013 | CN103313718A Growth hormone secretion promoter |
| 09/18/2013 | CN103301344A Chinese medicine oral liquid applied to maintain beauty and keep young |
| 09/18/2013 | CN103301200A Astragalus membranaceus powder medicament as well as extraction method and use thereof |
| 09/18/2013 | CN103300651A Pillow for preventing and treating endocrine dyscrasia |
| 09/18/2013 | CN103300486A Endocrine dyscrasia prevention and treatment bellyband |
| 09/18/2013 | CN102743660B Chinese herbal tea and preparation method thereof |
| 09/18/2013 | CN102225047B Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
| 09/18/2013 | CN102018672B Freeze-dried liposome composition of water-soluble medicament and preparation method thereof |
| 09/18/2013 | CN101237851B Estrogen compositions for vaginal administration |
| 09/17/2013 | US8536156 Contraception process and administration form for the same |
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8535731 Use of extracts of the Cassia alata plant |
| 09/17/2013 | CA2610475C Derivative prodrugs of ethinyl estradiol |
| 09/12/2013 | WO2013133980A1 Nitroxy derivatives of soft steroids |
| 09/12/2013 | WO2013131125A1 Dietary supplement |
| 09/12/2013 | WO2013131124A1 Dietary supplement for pet mammals |
| 09/12/2013 | WO2012083259A3 Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production |
| 09/11/2013 | CN103288728A Naphthoyl amine derivative, and preparation method and application thereof |
| 09/11/2013 | CN103285282A Chinese medicament composition for treating hyperprolactinemia caused by antipsychotic medications |
| 09/11/2013 | CN103284971A Tablets with site- and time- controlled gastrointestinal release of active ingredient |
| 09/11/2013 | CN102688387B Medicine for treating subacute thyroiditis |
| 09/11/2013 | CN102389539B Pure traditional Chinese medicine preparation for removing speckle and beautifying, and preparation method of pulvis and particle of the preparation |
| 09/11/2013 | CN102093460B Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
| 09/11/2013 | CN101838327B Human IL-15 subtype protein and preparation method and application thereof |
| 09/10/2013 | US8530413 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 09/10/2013 | US8530191 Method for preventing formation of trisulfide derivatives of polypeptides |
| 09/10/2013 | US8530190 Disulfide crosslinked glycoprotein hormone analogs, and their preparation and use |
| 09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
| 09/10/2013 | CA2561014C Thioamide derivatives as progesterone receptor modulators |
| 09/06/2013 | WO2013128391A1 Synthetic polypeptides and uses thereof |
| 09/04/2013 | CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors |
| 09/04/2013 | CN103272220A Buserelin acetate lipid microbubble and preparation method thereof |
| 09/04/2013 | CN103272184A Preparation for treating hyperthyreosis |
| 09/04/2013 | CN103271904A Nitric oxide donor endothelin receptor antagonist as well as preparation method and application thereof |
| 09/04/2013 | CN103271902A Slightly-soluble medicine solid dispersion and preparation method thereof |
| 09/04/2013 | CN102698043B Medicinal combination for treating thyroid gland |
| 09/04/2013 | CN102579669B Chinese medicinal composition for nourishing qi and blood and conditioning menstruation and preparation method thereof |
| 09/04/2013 | CN101743316B Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524773 Utilization of dialkylfumarates |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | US8524663 Method for site-specific polyvalent display on polymers |
| 09/03/2013 | US8524446 Method for detecting adeno-associated virus |
| 09/03/2013 | US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 09/03/2013 | CA2565029C Immediate release pharmaceutical tablets with height greater than width |
| 09/03/2013 | CA2421865C Olfactory and pheromones g-protein coupled receptors |
| 08/29/2013 | WO2013124828A1 Substituted chroman compounds as calcium sensing receptor modulators |
| 08/29/2013 | WO2008004717A9 A stable liquid formulation of human growth hormone |
| 08/28/2013 | EP2631233A1 Antagonist for mutated androgen receptor |
| 08/28/2013 | EP2629784A1 A novel herbal oil for controlling blood sugar without risk of hypoglycemea |
| 08/28/2013 | CN103269720A Growth hormone conjugates |
| 08/28/2013 | CN103266012A Special tea oil for postpartum woman |
| 08/28/2013 | CN102026974B Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518893 Medical compositions containing ghrelin |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518882 Administering choline cytidine 5-pyrophosphate which raises levels of uridine or uridine phosphate; improving memory, learning, cognition, synaptic transmission, synthesis/release of neurotransmitters, and increasing brain phospholipid levels; Alzheimer's disease |
| 08/27/2013 | US8518430 Dry mouldable drug formulation |
| 08/27/2013 | CA2572325C Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 08/22/2013 | WO2013123218A1 Selective estrogen receptor modulators with short half-lives and uses thereof |
| 08/22/2013 | WO2013120771A1 Imidazolylketone derivatives asd aldosterone synthase inhibitors |
| 08/22/2013 | WO2013064830A3 Medical use |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/21/2013 | EP2628485A1 New use of chemical ingredients in cynomorium as phytoestrogen |
| 08/21/2013 | CN1976921B Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 08/21/2013 | CN103261167A Substituted 6,6-used nitrogenous heterocyclic compounds and uses thereof |
| 08/21/2013 | CN103254193A 黄嘌呤类化合物中间体及其制备方法 Xanthine compound intermediates and preparation method |
| 08/21/2013 | CN103254192A Xanthine compound, its salt, intermediates, preparation method and application |
| 08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
| 08/21/2013 | CN103251929A Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 08/21/2013 | CN103251843A Medicine for treating dairy cow disease of eating grass and not eating feed and preparation method |
| 08/21/2013 | CN103251631A Salicylate conjugates useful for treating metabolic disorders |
| 08/21/2013 | CN103251579A Substituted acylanilides and methods of use thereof |
| 08/21/2013 | CN102579422B Application of flavonoids compound in preparation of anti-metabolic disease medicine |
| 08/21/2013 | CN102441110B Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism |
| 08/21/2013 | CN102389459B Traditional Chinese medicine composition for treating simple goiter |
| 08/21/2013 | CN101856363B Application of Bortezomib in preparing drugs for curing POEMS syndrome |
| 08/21/2013 | CN101780268B Method and reagent for diagnosing, preventing and treating insulin resistance |
| 08/21/2013 | CN101415710B Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513187 Soft protease inhibitors, and pro-soft forms thereof |
| 08/15/2013 | WO2013064703A3 Fkbp subtype-specific rapamycin analogue for use in treatment of diseases |
| 08/14/2013 | EP2626070A2 Pharmaceutical and food composition for preventing or treating diabetes or obesity |
| 08/14/2013 | EP2624846A2 Nanoparticle-loaded cells |
| 08/14/2013 | EP2624845A2 Enhanced msc preparations |
| 08/14/2013 | CN103249414A Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors |
| 08/14/2013 | CN103242192A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 08/14/2013 | CN103239730A Medical sodium alginate gel microsphere and preparation method and application thereof |
| 08/14/2013 | CN102764239B Propylthiouracil sustained release pellet |
| 08/14/2013 | CN102652757B Application of health-care drinking liquid containing deep seawater in preparation of medicaments or health-care products for preventing or treating metabolic syndrome |
| 08/14/2013 | CN102430028B Chinese medicinal patch for treating polycystic ovary syndrome and preparation method thereof |
| 08/14/2013 | CN101909604B Method of treating dysglycemia and glucose excursions |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/13/2013 | US8507467 Transdermally absorbable preparation |